• 1.

    Roberts DM, et al. Clinical pharmacokinetics in kidney disease: Application to rational design of dosing regimens. Clin J Am Soc Nephrol 2018; 13:12541263. doi: 10.2215/CJN.05150418

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Morrissey KM, et al. Renal transporters in drug development. Annu Rev Pharmacol Toxicol 2013; 53:503529. doi: 10.1146/annurev-pharmtox-011112-140317

  • 3.

    Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2024; 105:S117S314. doi: 10.1016/j.kint.2023.10.018

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Davison SN. Clinical pharmacology considerations in pain management in patients with advanced kidney failure. Clin J Am Soc Nephrol 2019; 14:917931. doi: 10.2215/CJN.05180418

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Wolf E, et al. Baclofen toxicity in kidney disease. Am J Kidney Dis 2018; 71:275280. doi: 10.1053/j.ajkd.2017.07.005

  • 6.

    Boschung-Pasquier L, et al. Cefepime neurotoxicity: Thresholds and risk factors. A retrospective cohort study. Clin Microbiol Infect 2020; 26:333339. doi: 10.1016/j.cmi.2019.06.028

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Behal ML, et al. Medication management in the critically ill patient with acute kidney injury. Clin J Am Soc Nephrol 2023; 18:10801088. doi: 10.2215/CJN.0000000000000101

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Vilay AM, et al. Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury. Crit Care 2008; 12:235. doi: 10.1186/cc7093

  • 9.

    Crass RL, et al. Renal dosing of antibiotics: Are we jumping the gun? Clin Infect Dis 2019; 68:15961602. doi: 10.1093/cid/ciy790

  • 10.

    Chawla LS, et al.; Acute Disease Quality Initiative Workgroup 16. Acute kidney disease and renal recovery: Consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol 2017; 13:241257. doi: 10.1038/nrneph.2017.2

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Haines RW, et al. Comparison of cystatin C and creatinine in the assessment of measured kidney function during critical illness. Clin J Am Soc Nephrol 2023; 18:9971005. doi: 10.2215/CJN.0000000000000203

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Bilbao-Meseguer I, et al. Augmented renal clearance in critically ill patients: A systematic review. Clin Pharmacokinet 2018; 57:11071121. doi: 10.1007/s40262-018-0636-7

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13.

    Jang SM, Awdishu L. Drug dosing considerations in continuous renal replacement therapy. Semin Dial 2021; 34:480488. doi: 10.1111/sdi.12972

  • 14.

    Kintzel PE, et al. Extracorporeal removal of antimicrobials during plasmapheresis. J Clin Apher 2003; 18:194205. doi: 10.1002/jca.10074

Pharmacokinetics and Kidney Clearance: A Nephrologist's Role in Drug Safety and Toxicology

Linda Awdishu Linda Awdishu, PharmD, FASN, MAS, is professor and Division Head, Clinical Pharmacy, University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences.

Search for other papers by Linda Awdishu in
Current site
Google Scholar
PubMed
Close
Restricted access
Save